Skip to Main Content.

Site navigation

Fidelity.com Home

Customer Service
Profile
Open an Account
Refer a Friend
Log In

Customer Service
Profile
Open an Account
Refer a Friend
Log Out

Search fidelity.com or get a quote

Accounts & Trade
Planning & Advice
News & Research
Investment Products
Why Fidelity

Customer Service
Profile
Open an Account
Refer a Friend
Log In

Customer Service
Profile
Open an Account
Refer a Friend
Log Out

Content and data provided by various third parties and Fidelity − Terms of Use

Research >
Stocks >
News & Events >

Stock Details

Enter Company or Symbol. Press down arrow for suggestions, or Escape to return to entry field.

View this information for the company or symbol View this information for the company or symbol

Find Symbol. Opens in new window.

Snapshot
Detailed Quote
Advanced Chart &
Technical Analysis
News & Events
Compare
Analyst Opinions
Research Reports
Key Statistics
Earnings
Dividends
Ownership & Insiders
Financial Statements
SEC Filings

RELATED RESOURCES

Stock Research Overview
Stock Screeners
Markets & Sectors
Fidelity Learning Center

Print Format

Change Text Size:

Default text sizeA
Larger text sizeA
Largest text sizeA

Form 3 bluebird bio, Inc. For: Jan 07 Filed by: Ibrahim Ramy

BY 10K Wizard
— 6:53 PM ET 01/11/2021

http://archive.fast-edgar.com/20210111/A32ZF22CZ222T2B222232MO24JNHZU227E32

Filed on: January 11, 2021

More BLUE News

BRIEF-Bluebird Bio Inc - Anticipates That Cash, Cash Equivalents, Marketable Securities Were About $1.3 Bln As Of December 31, 2020
Reuters - 8:16 AM ET 01/11/2021
BRIEF-Bluebird Bio To Separate Oncology Business Into Independent Company
Reuters - 7:11 AM ET 01/11/2021
Bluebird to spin off cancer drugs unit to focus on genetic diseases
Reuters - 6:58 AM ET 01/11/2021

Copyright 1998–2021 FMR LLC.
All rights reserved.

Terms of Use|
Privacy|
Security|
Site Map